Interleukin-17 promotes development of castration-resistant prostate cancer potentially through creating an immunotolerant and pro-angiogenic tumor microenvironment

BACKGROUND: Interleukin-17 (IL-17) has been demonstrated to promote formation and growth of hormone-naïve prostate adenocarcinoma in mice. IL-17’s role in development of castration-resistant prostate cancer is unknown. In the present study, we investigated IL-17’s role in castration-resistant prosta...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zhang, Qiuyang, Liu, Sen, Zhang, Qingsong, Xiong, Zhenggang, Wang, Alun R., Myers, Leann, Melamed, Jonathan, Tang, Wendell W., You, Zongbing
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063299/
https://ncbi.nlm.nih.gov/pubmed/24691769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22805
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items